Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatmentresistant depression

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 51, Issue 4, 2012, Pages 404-411

  McMakin, Dana L ^a   Olino, Thomas M ^a   Porta, Giovanna ^a   Dietz, Laura J ^a   Emslie, Graham ^b   Clarke, Gregory ^c   Wagner, Karen Dineen ^f   Asarnow, Joan R ^d   Ryan, Neal D ^a   Birmaher, Boris ^a   Shamseddeen, Wael ^g   Mayes, Taryn ^b   Kennard, Betsy ^b   Spirito, Anthony ^e   Keller, Martin ^e   Lynch, Frances L ^c   Dickerson, John F ^c   Brent, David A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c CENTER FOR HEALTH RESEARCH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BROWN UNIVERSITY   (United States)

^f University of Texas Medical Branch School of Medicine   (United States)

^g ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

adolescence; clinical trial; cognitive behavioral therapy; depression; treatment resistant

Indexed keywords

CITALOPRAM; ESCITALOPRAM; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADOLESCENT; ADULT; ANHEDONIA; ARTICLE; COGNITION; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; AFFECT; ANHEDONIA; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DOUBLE-BLIND METHOD; DRUG RESISTANCE; DRUG SUBSTITUTION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; PERSONALITY ASSESSMENT; PSYCHOMETRICS; PSYCHOTHERAPY; SEROTONIN UPTAKE INHIBITORS;

EID: 84859086857     PISSN: 08908567     EISSN: 15275418     Source Type: Journal    
DOI: 10.1016/j.jaac.2012.01.011     Document Type: Article

References (36)

1. TADS Team The Treatment for Adolescents with Depression Study (TADS): Long-term effectiveness and safety outcomes Arch Gen Psychiatry 64 2007 1132 1144
2. B. Kennard, S. Silva, B. Vitiello Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS) J Am Acad Child Adolesc Psychiatry 45 2006 1404 1411 (Pubitemid 44900913)
3. D.A. Brent, G. Emslie, G. Clarke Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial JAMA 299 2008 901 913 (Pubitemid 351397065)
4. G.J. Emslie, T. Mayes, G. Porta Treatment of Resistant Depression in Adolescents (TORDIA): Week 24 outcomes Am J Psychiatry 167 2010 782 791
5. B. Vitiello, G. Emslie, G. Clarke Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: A follow-up study of the TORDIA sample J Clin Psychiatry 72 2010 388 396
6. B.D. Kennard, S.G. Silva, S. Tonev Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): Acute and long-term outcomes J Am Acad Child Adolesc Psychiatry 48 2009 186 195
7. R. Tao, G. Emslie, T. Mayes, P. Nakonezny, B. Kennard, C. Hughes Early prediction of acute antidepressant treatment response and remission in pediatric major depressive disorder J Am Acad Child Adolesc Psychiatry 48 2009 71 78
8. D.A. Brent, F.T. Maalouf Pediatric depression: Is there evidence to improve evidence-based treatments? J Child Psychol Psychiatry 50 2009 143 152
9. J.R. Asarnow, G. Emslie, G. Clarke Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: Predictors and moderators of treatment response J Am Acad Child Adolesc Psychiatry 48 2009 330 339
10. D.A. Brent, D.J. Kolko, B. Birmaher Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression J Am Acad Child Adolesc Psychiatry 37 1998 906 914 (Pubitemid 28406737)
11. J. Curry, P. Rohde, A. Simons Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS) J Am Acad Child Adolesc Psychiatry 45 2006 1427 1439 (Pubitemid 44900916)
12. B. Birmaher, D.A. Brent, D. Kolko Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder Arch Gen Psychiatry 57 2000 29 36 (Pubitemid 30035656)
13. G. Clarke, P.M. Lewinsohn, J. Andrews, J.R. Seeley, J. Williams Cognitive-behavioral group treatment of adolescent depression: Prediction of outcome Behav Ther 23 1992 341 354
14. P. Rohde, J.R. Seeley, N.K. Kaufman, G.N. Clarke, E. Stice Predicting time to recovery among depressed adolescents treated in two psychosocial group interventions J Consult Clin Psychol 74 2006 80 88
15. M.H. Trivedi, E. Hollander, D. Nutt, P. Blier Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression J Clin Psychiatry 69 2008 246 258 (Pubitemid 351469268)
16. B.I. Goldstein, W. Shamseddeen, A. Spirito Substance use and the Treatment of Resistant Depression in Adolescents J Am Acad Child Adolesc Psychiatry 48 2009 1182 1192
17. J. Kaufman, B. Birmaher, D. Brent Schedule for Affective Disorders and Schizophrenia for School-Age ChildrenPresent and Lifetime Version (K-SADS-PL): Initial reliability and validity data J Am Acad Child Adolesc Psychiatry 36 2011 980 988
18. A. Rush, H.C. Kraemer, H.A. Sackeim Report by the ACNP Task Force on response and remission in major depressive disorder Neuropsychopharmacology 31 2006 1841 1853
19. R. Mallick, J. Chen, A. Entsuah, A.F. Schatzberg Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: A comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo J Clin Psychiatry 64 2003 321 330 (Pubitemid 36457331)
20. F.L. Lynch, J.F. Dickerson, G. Clarke Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: Treatment of SSRI-Resistant Depression in Adolescents trial findings Arch Gen Psychiatry 68 2011 253 262
21. M.E. Domino, B.J. Burns, S.G. Silva Cost-effectiveness of treatments for adolescent depression: Results from TADS Am J Psychiatry 165 2008 588 596 (Pubitemid 351705335)
22. R. Tao, G. Emslie, T.L. Mayes, P.A. Nakonezny, B.D. Kennard Symptom improvement and residual symptoms during acute antidepressant treatment in pediatric major depressive disorder J Child Adolesc Psychopharmacol 20 2010 423 430
23. D.A. Pizzagalli, A.J. Holmes, D.G. Dillon Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder Am J Psychiatry 166 2009 702 710
24. B.L. Fredrickson The role of positive emotions in positive psychology: The broaden-and-build theory of positive emotions Am Psychologist 56 2001 218 226 (Pubitemid 33609217)
25. J.T. Larsen, A.P. McGraw, J.T. Cacioppo Can people feel happy and sad at the same time? J Personal Soc Psychol 81 2001 684 696 (Pubitemid 33597810)
26. C.J. Norris, J. Gollan, G.G. Berntson, J.T. Cacioppo The current status of research on the structure of evaluative space Biol Psychol 84 2010 422 436
27. B.D. Kennard, G.N. Clarke, V. Weersing Effective components of TORDIA cognitive-behavioral therapy for adolescent depression: Preliminary findings J Consult Clin Psychol 77 2009 1033 1041
28. J.N. Giedd The teen brain: insights from neuroimaging J Adolesc Health 42 2008 335 343 (Pubitemid 351381455)
29. C.G. Davey, M. Yucel, N.B. Allen The emergence of depression in adolescence: Development of the prefrontal cortex and the representation of reward Neurosci Biobehav Rev 32 2008 1 19 (Pubitemid 350160954)
30. E.E. Forbes Where's the fun in that? Broadening the focus on reward function in depression Biol Psychiatry 66 2009 199 200
31. J. Wacker, D.G. Dillon, D.A. Pizzagalli The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: Integration of resting EEG, fMRI, and volumetric techniques NeuroImage 46 2009 327 337
32. J. Rottenberg, K.L. Kasch, J.J. Gross, I.H. Gotlib Sadness and amusement reactivity differentially predict concurrent and prospective functioning in major depressive disorder Emotion 2 2002 135 146
33. J.S. Silk, E.E. Forbes, D.J. Whalen Daily emotional dynamics in depressed youth: A cell phone ecological momentary assessment study J Exp Child Psychol 110 2011 241 257
34. E.E. Forbes, T.M. Olino, N.D. Ryan Reward-related brain function as a predictor of treatment response in adolescents with major depressive disorder Cogn Affect Behav Neurosci 10 2010 107 118
35. K.L. Kasch, J. Rottenberg, B.A. Arnow, I.H. Gotlib Behavioral activation and inhibition systems and the severity and course of depression J Abnorm Psychol 111 2002 589 597 (Pubitemid 35247004)
36. M.T. Treadway, D.H. Zald Reconsidering anhedonia in depression: Lessons from translational neuroscience Neurosci Biobehav Rev 35 2011 537 555